బ్రెయిన్ ట్యూమర్ (గ్లియోమా)

High grade gliomas, particularly glioblastoma, are among the most aggressive brain tumors and are associated with poor outcomes despite standard treatment. Many patients, especially older adults or those with poor general health, are not suitable for surgery and have a life expectancy of less than 12 months. Current standard includes a shortened course of radiotherapy (over 3 weeks) combined with chemotherapy using temozolomide (TMZ), which offers limited survival benefits. This study aims to explore whether delivering radiotherapy in a shorter duration (1 or 2 weeks) at a higher dose, guided …

స్పాన్సర్: టాటా మెమోరియల్ సెంటర్
NCT07338539 ఆన్ ClinicalTrials.gov
రిజిస్ట్రీలో చివరిసారిగా అప్‌డేట్ అయిన తేదీ 18 మే 2026 · మేము చదివిన తేదీ 20 అక్టోబర్ 2026